It is a novel, oral controlled drug delivery system based on pre-defined, precise and selective surface exposure.
The technology utilizes combination of functional coatings which can modulate drug release profile as desired to match the complex clinical requirement.
The technology can accommodate molecules with a wide range of solubility profile or it can be employed to formulate chemically non – compatible molecule combination which may have potential clinical significance as a fixed dose combination.
This technology accommodates very high drug to excipient ratio which allows formulating compact tablets and in turn improves patient compliance. This feature holds special significance while designing a formulation for drug molecules with high daily dose and moderate to high aqueous solubility.
The unique combination of excipients used in the technology helps to design a robust formulation which can negate food effect and avoid alcohol induced dose dumping. Alcohol induced dose dumping has been identified by FDA as important evaluating parameter while reviewing applications for extended release formulations due to high risk they pose owing to their high drug content.
The technology has been commercially tested in several products in USA and other geographies.
It is a novel oral controlled drug delivery system based on pre-defined, precise and selective surface exposure